[Bronchial carcinoma screening with low dosage CT. Current status].
Lung cancer is the most common cause of death from malignancy. It is characterized by a favourable prognosis when treated in early stages and a poor prognosis in advanced stages. Populations at risk are relatively well defined, i.e. heavy smokers and workers exposed to asbestos and radon. Therefore, early detection using diagnostic techniques promises reduction of mortality from this tumor. Previous studies using chest radiography and sputum cytology were, however, disappointing due to poor sensitivity of these tests for early tumor stages. The new technique of low-dose computed tomography provides both high sensitivity for small tumors and a comfortable examination. As small benign pulmonary nodules are common reliable non-invasive diagnostic algorithms are required for classification of nodules. Preliminary studies using low-dose CT screening in smokers have provided promising results. Prior to a wide application of the technique in clinical routine more data are required as to inclusion criteria, examination intervals and the effect of screening on mortality reduction.
Diederich
S
S
Institut für Klinische Radiologie, Universitätsklinikum, Albert-Schweitzer-Str. 33, 48129 Münster. stefan.diederich@uni-muenster.de
Wormanns
D
D
Heindel
W
W
D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008403:Mass Screening; D009367:Neoplasm Staging; D011379:Prognosis; D011829:Radiation Dosage; D011856:Radiographic Image Enhancement; D012907:Smoking / Q000009:adverse effects; D014057:Tomography, X-Ray Computed